Add listing
    0
    Add listing

    Proclarix

    Indicaton

    Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.

    Therapeutic indications
    Type of product
    Table
    • Phase
      Marketed
    • Available in
      EU, Switzerland

    You may also be interested in